Evolution Research Group, LLC (ERG) is the largest, independent clinical research site company in the U.S., and the leader in early and late phase CNS Study execution. ERG’s portfolio of 12 fully owned and operated clinical research units allows clients access to more than 400 beds, 3 surgical centers, state-of-the-art imaging, KOLs in multiple therapeutic specialties, and an affiliate member network of 12 high quality, experienced sites. ERG has a proven track record of executing complex trials in specialized an diverse populations across all age groups. ERG is one of the only site groups that has a pediatric PK unit with the expertise to handle CNS populations.
ERG’s account directors, along with our clinical, operational, recruitment, quality and administration teams work collaboratively with clients to ensure study objectives in a timely fashion.
Although ERG is a fully-integrated platform, it has maintained the local identity of its research sites. Patient engagement is a defining core competency that unites out networks, both portfolio and affiliate members. ERG’s outreach to patients results in delivery of high quality study data, but begins with understanding first hand their unmet medical needs, seeking input on protocol feasibility and providing education and awareness of the risks and benefits of clinical trial participation. By partnering with patients and advocates throughout the development process, ERG improves the quality and conduct of clinical trials for both the sponsors and the trial participants. We are proud to contribute to the delivery of life-changing new medicines in multiple therapeutic areas.
Our network is comprised of 24 clinical research sites:
12 Inpatient units (with >400 beds)
- Clinical Pharmacology
- Clinical Research
- Pediatric and Adolescent with PK Ward
- Specialty Post-OP Pain Clinics
29 Outpatient Units